NDC11 00078082798
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00078-0827-98 | 00078-0827 |
| 00078-827-98 | 00078-827 |
| 0078-0827-98 | 0078-0827 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| BEOVU | BROLUCIZUMAB | Novartis Pharmaceuticals Corporation | 5d1dc1fa-a2d3-46ed-9e9a-c1a036590d3d | 2025-11-03 | Warnings, Adverse reactions | 0078-0827-98 0078-0827 00078082798 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.